The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
IMpower150: Exploratory efficacy analysis in patients (pts) with bulky disease.
 
Robert M. Jotte
Honoraria - Bristol-Myers Squibb; Roche/Genentech
Speakers' Bureau - Bristol-Myers Squibb; Roche/Genentech
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche/Genentech
 
Marta Batus
No Relationships to Disclose
 
Eric Bernicker
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Guardant Health; Pfizer
Research Funding - EMD Serono
 
Mehmet Sitki Copur
Honoraria - Amgen; Amgen; AstraZeneca; Bristol-Myers Squibb; Dava Oncology
 
Eli Kirshner
Speakers' Bureau - AstraZeneca
 
Han A. Koh
Research Funding - Lilly (Inst)
 
Mark Kozloff
Honoraria - Abbvie; Genentech/Roche
Consulting or Advisory Role - Abbvie; Genentech/Roche
Speakers' Bureau - Abbvie; Amgen; Bayer; Boehringer Ingelheim; Celgene; Celgene; Genentech/Roche; Merck; Novartis; Novartis; Rigel; Tesaro
 
Kert D. Sabbath
Stock and Other Ownership Interests - Johnson & Johnson
 
Janakiraman Subramanian
Consulting or Advisory Role - AstraZeneca; Biocept; Boehringer Ingelheim; Novartis; Pfizer
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim
Research Funding - Biocept; Paradigm
 
Wei Yu
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Michael Nowicki
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Ilze Bara
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Gene Grant Finley
Stock and Other Ownership Interests - Proteostasis Therapeutics
Speakers' Bureau - Bristol-Myers Squibb; Roche; Roche
Research Funding - AstraZeneca (Inst); BeyondSpring Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Genentech/Roche